{"disease":{"id":"medical-oncology","name":"medical oncology"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT05385718","title":"Ezra Faster Scan Study","phase":"","overall_status":"COMPLETED","enrollment_count":694,"lead_sponsor_name":"Ezra AI, Inc.","has_results":false},{"nct_id":"NCT06097533","title":"Improvement of Quality of Life by Cannabinoids in Oncologic Patients","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":170,"lead_sponsor_name":"University Hospital Schleswig-Holstein","has_results":false},{"nct_id":"NCT05781295","title":"Multicentre Randomised Study Comparing a Taurolidine Lock and a Standard Saline Lock in Paediatric Oncology","phase":"NA","overall_status":"RECRUITING","enrollment_count":148,"lead_sponsor_name":"Institut Curie","has_results":false},{"nct_id":"NCT02366949","title":"Phase I Study of Oral BAY 1217389 in Combination With Intravenous Paclitaxel","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":75,"lead_sponsor_name":"Bayer","has_results":false},{"nct_id":"NCT02138812","title":"Phase I Dose Escalation of Oral BAY1161909 in Combination With Intravenous Paclitaxel","phase":"PHASE1","overall_status":"TERMINATED","enrollment_count":69,"lead_sponsor_name":"Bayer","has_results":false},{"nct_id":"NCT02824042","title":"Thorough ECG (Electrocardiogram) and Drug Interaction Study With Anetumab Ravtansine and Itraconazole","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":63,"lead_sponsor_name":"Bayer","has_results":false},{"nct_id":"NCT02253420","title":"COPANLISIB (BAY80-6946) Drug-drug Interaction and Cardiovascular Safety Study in Advanced Solid Tumor and Non-Hodgkin's Lymphoma Patients","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":51,"lead_sponsor_name":"Bayer","has_results":false},{"nct_id":"NCT02639091","title":"Phase Ib Study of Anetumab Ravtansine in Combination With Pemetrexed and Cisplatin in Mesothelin-expressing Solid Tumors","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":36,"lead_sponsor_name":"Bayer","has_results":false},{"nct_id":"NCT01409135","title":"A Study of the Safety and Pharmacokinetics of AGS-22M6E in Subjects With Malignant Solid Tumors That Express Nectin-4","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":34,"lead_sponsor_name":"Astellas Pharma Inc","has_results":false},{"nct_id":"NCT05359848","title":"A Pilot, Feasibility Study of Intermittent Caloric Restriction Plus Plant-based Diet in Cancer Patients Receiving Chemotherapy","phase":"NA","overall_status":"RECRUITING","enrollment_count":30,"lead_sponsor_name":"State University of New York at Buffalo","has_results":false},{"nct_id":"NCT02368951","title":"Phase I, Dose-escalation Trial of BAY1187982 in Subjects With Advanced Solid Tumors Known to Express Fibroblast Growth Factor Receptor 2 (FGFR2)","phase":"PHASE1","overall_status":"TERMINATED","enrollment_count":20,"lead_sponsor_name":"Bayer","has_results":false},{"nct_id":"NCT02439346","title":"Phase I Dose Escalation and Expansion of Oral BAY 1143269 in Combination With Intravenous Docetaxel","phase":"PHASE1","overall_status":"TERMINATED","enrollment_count":15,"lead_sponsor_name":"Bayer","has_results":false},{"nct_id":"NCT04557696","title":"A Study to Implement and Evaluate REFLECT Communication Curriculum for Oncology Based Medical Graduate Students","phase":"NA","overall_status":"TERMINATED","enrollment_count":4,"lead_sponsor_name":"Mayo Clinic","has_results":false}],"total":13},"guidelines":[],"source":"Drug Landscape verified database"}